Stay updated on AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.

Latest updates to the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov record for the completed Phase 1 AEB1102 dose-escalation study is displayed, with details about its advanced solid tumor cohorts, study methods, eligibility, and results measures.SummaryDifference61%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0, while the study page remains an error page.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA banner about an NIH-wide terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference1%

- Check35 days agoChange DetectedThe site footer revision marker changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now displays a 403 error page, replacing the previous content with an error layout. This blocks access to the trial details and location information shown on the page.SummaryDifference19%

- Check56 days agoChange DetectedThe page's revision indicator was updated from v3.6.6 to v3.7.0, signaling a software update to the page. No study details or content are changed as a result.SummaryDifference0.1%

Stay in the know with updates to AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.